Search for Clinical Trials
This study is being done to learn more about the safety and effectiveness of an investigational oral medication called ORIN1001 for people with…
This study is being done to see if losing weight may help prevent breast cancer from coming back.
A study to determine the change from baseline to post-treatment Ki67 in some breast cancer tissue.
This study is being done to evaluate the safety and effectiveness of three different drug combinations for patients with HER2-positive metastatic…
The main purpose of this study is to look at the safety and effectiveness of the standard anti-HER2-targeted therapies.
A study to determine if the combination of avelumab with several different drugs is safe and effective for treating patients with metastatic triple-…
This study is to find out if patients with HER2-positive breast cancer who have no cancer remaining at surgery after 12 weeks of chemotherapy and 2…
This study is being done to find out if tucatinib plus T-DM1 works better to treat breast cancer than T-DM1 alone.
Tucatinib is a type of drug…
M16-067: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Subjects…
RPC-3201: Induction Study #1 - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for…
